Protective Effect of Magnesium-25 Carrying Porphyrin-Fullerene Nanoparticles on Degeneration of Dorsal Root Ganglion Neurons and Motor Function in Experimental Diabetic Neuropathy

Basic and Clinical Pharmacology and Toxicology

Volumn 109, Issue 5, 2011, Pages 381-386

  Hosseini, Asieh ^a   Abdollahi, Mohammad ^a   Hassanzadeh, Gholamreza ^a   Rezayat, Mahdi ^a   Hassani, Shokoufeh ^a   Pourkhalili, Nazila ^a   Tabrizian, Kaveh ^a   Khorshidahmad, Tina ^a   Beyer, Cordian ^b   Sharifzadeh, Mohammad ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FULLERENE DERIVATIVE; MAGNESIUM 24 PORPHYLLEREN MC16; MAGNESIUM 25 PORPHYLLEREN MC16; MAGNESIUM CHLORIDE; MAGNESIUM DERIVATIVE; NANOPARTICLE; NEUROPROTECTIVE AGENT; PORPHYRIN DERIVATIVE; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG EFFICACY; FUNCTION TEST; INSULIN DEPENDENT DIABETES MELLITUS; LD 50; MALE; MORPHOMETRICS; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SPINAL GANGLION; STREPTOZOCIN DIABETES;

ANIMALS; BIOLOGICAL MARKERS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; FULLERENES; GANGLIA, SPINAL; MAGNESIUM; MALE; METAL NANOPARTICLES; NEURONS; OXIDATIVE STRESS; PERIPHERAL NERVES; PORPHYRINS; RATS; STREPTOZOCIN;

EID: 80054079081     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2011.00741.x     Document Type: Article

References (26)

1. Kannan V. Molecular mechanisms of diabetic neuropathy. Int J Diabetes Dev Ctries 2000;20:101-3.
2. Kamiya H, Zhangm W, Sima AA. Apoptotic stress is counterbalanced by survival elements preventing programmed cell death of dorsal root ganglions in subacute type 1 diabetic BB/Wor rats. Diabetes 2005;54:3288-95.
3. Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother 2005;59:365-73.
4. Yasuda H, Terada M, Maeda K, Kogawa S, Sanada M, Haneda M et al. Diabetic neuropathy and nerve regeneration. Prog Neurobiol 2003;69:229-85.
5. Noorafshan A, Ebrahimpoor MR, Sadeghi Y. Stereological study of the cells of dorsal root ganglia in male diabetic rats. APMIS 2001;109:762-6.
6. 2+-magnetic isotope effect. Eur J Med Chem 2009;44:1554-69.
7. Fernyhough P, Huang TJ, Verkhratsky A. Mechanism of mitochondrialdysfunction in diabetic sensory neuropathy. J Peripher Nerv Syst 2003;8:227-35.
8. Douglas W, Zochodne MD. Diabetic neuropathies. Neuromuscul Disord 2000;2:23-9.
9. Hosseini A, Sharifzadeh M, Rezayat SM, Hassanzadeh G, Hassani SH, Baeeri M et al. Benefit of magnesium-25 carrying porphyrinfullerene nanoparticles in experimental diabetic neuropathy. Int J Nanomedicine 2010;5:517-23.
10. Schmeichel AM, Schmelzer JD, Low PA. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes 2003;52:165-71.
11. Srinivasan S, Stevens M, Wiley JW. Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction. Diabetes 2000;49:1932-8.
12. Kessler JA, Black IB. Nerve growth factor stimulates development of substance P in the embryonic spinal cord. Brain Res 1981;208:135-45.
13. Jadavji NM, Kolb B, Metz GA. Enriched environment improves motor function in intact and unilateral dopamine-depleted rats. Neuroscience 2006;140:1127-38.
14. Azami K, Etminani M, Tabrizian K, Salar F, Belaran M, Hosseini A et al. The quantitative evaluation of cholinergic markers in spatial memory improvement induced by nicotine-bucladesine combination in rats. Eur J Pharmacol 2010;636:102-7.
15. Nakamura J, Koh N, Sakakibara F, Hamada Y, Wakao T, Hara T et al. Polyol pathway, 2, 3-diphosphoglycerate in erythrocytes and diabetic neuropathy in rats. Eur J Pharmacol 1995;294:207-14.
16. Nakamura J, Koh N, Sakakibara F, Hamada Y, Hara T, Sasaki H et al. Polyol pathway hyperactivity is closely related to carnitine deficiency in the pathogenesis of diabetic neuropathy of streptozotocin-diabetic rats. J Pharmacol Exp Ther 1998;287:897-902.
17. Kishi M, Tanabe J, Schmelzer JD, Low PA. Morphometry of dorsal root ganglion in chronic experimental diabetic neuropathy. Diabetes 2002;51:819-24.
18. Brussee V, Cunningham FA, Zochodne DW. Direct insulin signaling of neurons reverses diabetic neuropathy. Diabetes 2004;53:1824-30.
19. Bosi S, Da Ros T, Spalluto G, Prato M. Fullerene derivatives: an attractive tool for biological applications. Eur J Med Chem 2003;38:913-23.
20. Huang TJ, Sayers NM, Verkhratsky A, Fernyhough P. Neurotrophin-3 prevents mitochondrial dysfunction in sensory neurons of streptozotocin-diabetic rats. Exp Neurol 2005;194:279-83.
21. Wu AS, Kiaei M, Aguirre N, Crow JP, Calingasan NY, Browne SE et al. Iron porphyrin treatment extends survival in a transgenic animal model of amyotrophic lateral sclerosis. J Neurochem 2003;85:142-50.
22. Gilmore JL, Yi X, Quan L, Kabanov AV. Novel nanomaterials for clinical neuroscience. J Neuroimmune Pharmacol 2008;3:83-94.
23. Wang IC, Tai LA, Lee DD, Kanakamma PP, Shen CK, Luh TY et al. C(60) and water-soluble fullerene derivatives as antioxidants against radical-initiated lipid peroxidation. J Med Chem 1999;42:4614-20.
24. Kano K. Molecular complexes of water-soluble porphyrins. J Porphyr Phthalocyanines 2004;8:148-55.
25. Pawar R, Avramoff A, Domb AJ. Nanoparticles for crossing biological membranes. In: Kumar CSSR (ed.). Biological and Pharmacological Nanomaterials. Wiley-VCH, Weinheim-Baton Rouge, LA, 2007;349-93.
26. Gergely M, Lakatos I. Molecular and Cellular Cardiology. Alba Regia, Budapest, Szeged, 1999.